Product logins

Find logins to all Clarivate products below.


Blog: Oncology

Here you will find relevant articles and insight into all Clarivate related products and news.

Seven companies forging new paths in women’s health Seven companies forging new paths in women’s health
Blog November 13, 2025
Seven companies forging new paths in women’s health
Biopharma Biotech Business Development
Six companies enabling precision interventions for “undruggable” targets Six companies enabling precision interventions for “undruggable” targets
Blog October 7, 2025
Six companies enabling precision interventions for “undruggable” targets
Biopharma Biotech Business Development
These six radioligand therapy companies to watch are ushering in a new era of precision oncology These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Blog June 18, 2025
These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Biopharma Clinical research Market Access
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Blog June 17, 2024
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Clinical research Early drug development research Oncology
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs
Clinical research Clinical trials Consulting Resource Center
Pharma is placing bigger bets on fewer, more strategic assets and platforms Pharma is placing bigger bets on fewer, more strategic assets and platforms
Blog May 8, 2024
Pharma is placing bigger bets on fewer, more strategic assets and platforms
Oncology Pharma Portfolio strategy
What to watch in the life sciences in 2024 What to watch in the life sciences in 2024
Blog December 14, 2023
What to watch in the life sciences in 2024
Oncology Pharma Portfolio strategy
Five points on CMS's first ten picks for price negotiations Five points on CMS's first ten picks for price negotiations
Blog October 25, 2023
Five points on CMS's first ten picks for price negotiations
Health policy Inflation Reduction Act IRA

Oncology

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
Seven companies forging new paths in women’s health Seven companies forging new paths in women’s health
Blog November 13, 2025
Seven companies forging new paths in women’s health
Six companies enabling precision interventions for “undruggable” targets Six companies enabling precision interventions for “undruggable” targets
Blog October 7, 2025
Six companies enabling precision interventions for “undruggable” targets
These six radioligand therapy companies to watch are ushering in a new era of precision oncology These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Blog June 18, 2025
These six radioligand therapy companies to watch are ushering in a new era of precision oncology
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Blog June 17, 2024
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs
Pharma is placing bigger bets on fewer, more strategic assets and platforms Pharma is placing bigger bets on fewer, more strategic assets and platforms
Blog May 8, 2024
Pharma is placing bigger bets on fewer, more strategic assets and platforms
What to watch in the life sciences in 2024 What to watch in the life sciences in 2024
Blog December 14, 2023
What to watch in the life sciences in 2024
Five points on CMS's first ten picks for price negotiations Five points on CMS's first ten picks for price negotiations
Blog October 25, 2023
Five points on CMS's first ten picks for price negotiations
Four key points on the Inflation Reduction Act Four key points on the Inflation Reduction Act
Blog August 8, 2023
Four key points on the Inflation Reduction Act
Seven RNA technology companies to keep an eye on Seven RNA technology companies to keep an eye on
Blog November 8, 2022
Seven RNA technology companies to keep an eye on